Novartis sues India's Cipla over respiratory drug Onbrez

December 17, 2014 1:25 PM

6 0

Novartis sues India's Cipla over respiratory drug Onbrez

MUMBAI (Reuters) - Swiss drugmaker Novartis AG said on Wednesday it had sued India's Cipla Ltd for infringing patents covering its respiratory drug Onbrez, a month after Cipla launched a copy at a fifth of the original drug's price.

Cipla, India's fourth-largest drugmaker by revenue, launched its copy of Onbrez in New Delhi in October, citing urgent unmet need for the drug in India.

Read more

To category page

Loading...